Live Chat ×
Skip to main content

Head and Neck Pathology: Start to Finish

Evaluated by: David B. Kaminsky, M.D., FIAC on June 25, 2017
Original release date: November 15, 2017
Access to this course expires on: June 23, 2020, at 11:59 PM Pacific Time
CME/SAMs 11.5

Course Description:
The complexities of the head and neck region create a unique set of difficulties for pathologists, particularly if they are neuroendocrine specimens handled by general pathologists who do not see a high volume of these cases. The subtleties in the spectrum of their presentation in the context of differential diagnostic alternatives create a professional practice gap that can be closed by personalized, mentoring instruction with experts at multi-head microscopes. This course reinforces diagnostic cognitive strategies and underscores the pathologist as an integral player in the multidisciplinary team responsible for correct diagnosis and assignment to therapy. 

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:

  • Understand the significant FNA findings to meaningfully distinguish salivary gland tumors
  • Apply clinically relevant criteria to separate oral inflammatory lesions
  • Use the new and correct terminology for thyroid neoplasms, with attention to outcome differences
  • Apply sequential, targeted and limited immunohistochemistry studies to distinguish sinonasal tract tumors
  • Develop reproducible histologic criteria for tumor and dysplasia grading of head and neck neoplasms

Continuing Medical Education and Continuing Certification
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 11.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) and Lifelong Learning (Part II) credit for the purpose of meeting the ABPath requirements for Continuing Certification (CC). Registrants must take and pass the post-test in order to claim SAMs credit. Physicians can earn a maximum of 11.5 SAM/Part II credit hours.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reporting relevant financial relationships: Sylvia L. Asa, M.D., Ph.D: Honorarium, Leica Aperio Pathology Imaging
The following faculty reported no relevant financial relationships: Lester D.R. Thompson, M.D., Lester Layfield, M.D., Susan Muller, D.M.D., MS 

The following IM Coordinator reported no relevant financial relationships: Raja Seethala, MD

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here.

Not a Member? 
Click Here